26Aug 2023
Apoptotic cells for treatment of acute respiratory distress syndrome associated with COVID-19

Apoptotic cells for treatment of acute respiratory distress syndrome associated with COVID-19

Allocetra™-OTS, a cellular immunomodulatory therapy, exhibited safety and efficacy in treating severe/critical COVID-19 with acute respiratory distress syndrome (ARDS). No serious adverse events were reported among patients who experienced rapid ARDS resolution and reduced inflammation markers. Promising results suggest Allocetra™-OTS's potential for managing COVID-19 hyper-inflammation.

  • #family health

Like

Save

Share